AIGEN INVESTMENT MANAGEMENT, LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 119 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$509,644
+74.3%
8,868
+13.7%
0.08%
+87.5%
Q1 2023$292,463
+17.0%
7,799
-37.1%
0.04%
-9.1%
Q2 2021$250,000
-15.3%
12,390
-22.9%
0.04%
+12.8%
Q1 2021$295,000
-31.1%
16,077
-24.4%
0.04%
-30.4%
Q4 2020$428,000
-4.5%
21,272
-11.0%
0.06%
-1.8%
Q3 2020$448,000
+853.2%
23,900
+662.6%
0.06%
+850.0%
Q1 2020$47,000
+88.0%
3,134
+146.6%
0.01%
+50.0%
Q4 2019$25,0001,2710.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders